1-5 of 5
Franklin V. Peale, Jr.
Close
Sort by
Journal Articles

Response to Venetoclax in Combination with Low Intensity Therapy (LDAC or HMA) in Untreated Patients with Acute Myeloid Leukemia Patients with IDH, FLT3 and Other Mutations and Correlations with BCL2 Family Expression

Brenda J Chyla, PhD, Jason Harb, PhD, Christine Mantis, PhD, Jacob J Riehm, PhD, Jeremy A. Ross, PhD, Yan Sun, PhD, Xin Huang, PhD MD, Qi Jiang, PhD, Monique Dail, PhD, Franklin V. Peale, Jr., MD PhD, Jalaja Potluri, MD, John Hayslip
Journal: Blood
Blood (2019) 134 (Supplement_1): 546.
https://doi.org/10.1182/blood-2019-128373
Published: 2019
Journal Articles

BCL2 Expression Identifies a Population with Unmet Medical Need in Previously Untreated (1L) Patients with DLBCL

Edith Szafer-Glusman, Franklin V. Peale, Jr., Guiyuan Lei, Anja Mottok, Pedro Farinha, Jill Ray, Thalia A. Farazi, Martin Kornacker, Mikkel Z. Oestergaard, Juan Liu, Randy D. Gascoyne, MD, Elizabeth Punnoose
Journal: Blood
Blood (2017) 130 (Supplement 1): 418.
https://doi.org/10.1182/blood.V130.Suppl_1.418.418
Published: 2017
Journal Articles

A Simulation Analysis to Evaluate the Effect of Prospective Biomarker Testing on Progression-Free Survival (PFS) in DLBCL

Edith Szafer-Glusman, Juan Liu, Franklin V. Peale, Jr., Thalia A. Farazi, Jill Ray, Carsten Horn, Mikkel Z. Oestergaard, Martin Kornacker, Laurie H. Sehn, MDMPH, Günter Fingerle-Rowson, Jeffrey M. Venstrom, Michelle Byrtek, Elizabeth Punnoose
Journal: Blood
Blood (2017) 130 (Supplement 1): 419.
https://doi.org/10.1182/blood.V130.Suppl_1.419.419
Published: 2017
Journal Articles

A Favorable BCL-2 Family Expression Profile May Explain the Increased Susceptibility of the t(11;14) Multiple Myeloma Subgroup to Single Agent Venetoclax

Jenny Wu, Jeremy Ross, Franklin V. Peale, Jr., John D Shaughnessy, Jr., PhD, Ryan K Van Laar, PhD, Gareth J Morgan, MD PhD, Jeffrey M Venstrom, Elizabeth A. Punnoose, PhD
Journal: Blood
Blood (2016) 128 (22): 5613.
https://doi.org/10.1182/blood.V128.22.5613.5613
Published: 2016
Journal Articles

Prevalence and Prognostic Value of BCL2 and MYC Protein Expression within ABC and GCB Subtypes in Patients with Previously Untreated, Diffuse Large B-Cell Lymphoma: Analysis from the Phase III MAIN Study

Elizabeth Punnoose, Franklin V. Peale, Jr., Guiyuan Lei, Thomas Sandmann, Richard Bourgon, Edith Szafer-Glusman, An Do, Randy D. Gascoyne, Gilles A. Salles, MD PhD, John F. Seymour, MBBS, PhD, Marek Trneny, Laurie H. Sehn, F. Javier Munoz, Kirsten E. Mundt, PhD
Journal: Blood
Blood (2015) 126 (23): 3971.
https://doi.org/10.1182/blood.V126.23.3971.3971
Published: 2015